Cantor Fitzgerald Forecasts Increased Earnings for Teradyne

Teradyne, Inc. (NASDAQ:TER) – Equities research analysts at Cantor Fitzgerald boosted their FY2025 earnings per share (EPS) estimates for Teradyne in a research note issued on Thursday, July 31st. Cantor Fitzgerald analyst C. Muse now expects that the company will earn $3.10 per share for the year, up from their previous estimate of $2.75. Cantor Fitzgerald has a “Overweight” rating and a $105.00 price target on the stock. The consensus estimate for Teradyne’s current full-year earnings is $3.88 per share. Cantor Fitzgerald also issued estimates for Teradyne’s FY2026 earnings at $4.70 EPS.

Teradyne (NASDAQ:TER) last released its quarterly earnings results on Tuesday, July 29th. The company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.03. The firm had revenue of $651.80 million for the quarter, compared to analysts’ expectations of $649.02 million. Teradyne had a net margin of 16.59% and a return on equity of 18.16%. The business’s quarterly revenue was down 10.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.86 earnings per share.

Several other research firms have also recently weighed in on TER. Morgan Stanley raised shares of Teradyne from an “underweight” rating to an “equal weight” rating and upped their price target for the stock from $74.00 to $100.00 in a report on Thursday. KeyCorp reaffirmed a “sector weight” rating on shares of Teradyne in a report on Thursday, April 17th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $102.00 price target (up previously from $88.00) on shares of Teradyne in a report on Thursday, July 17th. Stifel Nicolaus upped their price target on shares of Teradyne from $85.00 to $100.00 and gave the stock a “hold” rating in a report on Thursday. Finally, UBS Group reissued a “buy” rating and issued a $130.00 target price (up previously from $120.00) on shares of Teradyne in a research note on Thursday. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $114.44.

Teradyne Stock Performance

Teradyne stock opened at $104.16 on Monday. The stock has a market cap of $16.71 billion, a P/E ratio of 36.04, a PEG ratio of 2.19 and a beta of 1.72. Teradyne has a fifty-two week low of $65.77 and a fifty-two week high of $144.16. The firm’s fifty day moving average price is $89.70 and its 200-day moving average price is $92.48.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of TER. Federated Hermes Inc. boosted its holdings in shares of Teradyne by 188.8% during the first quarter. Federated Hermes Inc. now owns 2,105,852 shares of the company’s stock worth $173,943,000 after purchasing an additional 1,376,631 shares during the period. AQR Capital Management LLC boosted its holdings in shares of Teradyne by 1,612.4% during the first quarter. AQR Capital Management LLC now owns 1,404,752 shares of the company’s stock worth $113,251,000 after purchasing an additional 1,322,716 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of Teradyne by 224.0% during the first quarter. Goldman Sachs Group Inc. now owns 1,851,684 shares of the company’s stock worth $152,949,000 after purchasing an additional 1,280,120 shares during the period. Ameriprise Financial Inc. boosted its holdings in shares of Teradyne by 28.3% during the fourth quarter. Ameriprise Financial Inc. now owns 4,828,689 shares of the company’s stock worth $608,025,000 after purchasing an additional 1,065,474 shares during the period. Finally, Balyasny Asset Management L.P. lifted its holdings in Teradyne by 142.6% in the fourth quarter. Balyasny Asset Management L.P. now owns 1,522,537 shares of the company’s stock worth $191,718,000 after buying an additional 894,849 shares during the period. 99.77% of the stock is owned by institutional investors.

Insider Activity

In other news, CEO Gregory Stephen Smith sold 554 shares of the firm’s stock in a transaction dated Wednesday, July 30th. The stock was sold at an average price of $105.73, for a total transaction of $58,574.42. Following the transaction, the chief executive officer directly owned 97,547 shares of the company’s stock, valued at approximately $10,313,644.31. This trade represents a 0.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.16% of the company’s stock.

Teradyne announced that its Board of Directors has approved a stock buyback program on Monday, April 28th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 8.1% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Teradyne Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Thursday, May 22nd were paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 22nd. Teradyne’s dividend payout ratio (DPR) is 16.61%.

Teradyne Company Profile

Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.